Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04624126 · ClinicalTrials.gov registry record · NA

External Device for Erectile Dysfunction (3D-Erect)

A NA study of Erectile Dysfunction and Impotentia Erigendi, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT04624126 is a NA study of Erectile Dysfunction and Impotentia Erigendi that is actively recruiting participants, run by Stanford University. The registered enrollment target is 9 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04624126, a NA study of Erectile Dysfunction and Impotentia Erigendi, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).

Interventions

  • DEVICE 3D-Erect

Study Locations (1)

California

  • Stanford Health Care, Stanford Hospital - Stanford

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2021-07-10
Est. Completion 2026-12
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04624126

The ClinicalTrials.gov registry entry for NCT04624126 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which 3D-Erect is the first listed.

NCT04624126 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04624126 about?

NCT04624126 is a clinical study titled "External Device for Erectile Dysfunction (3D-Erect)". The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).

What is the current status of trial NCT04624126?

This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2021-07-10. Estimated completion is 2026-12.

What conditions does trial NCT04624126 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Impotentia Erigendi.

What interventions are being tested in trial NCT04624126?

The interventions under investigation include: 3D-Erect (DEVICE).

Who is sponsoring clinical trial NCT04624126?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04624126 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.